These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28062695)

  • 21. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
    Mallevaey T; Selvanantham T
    Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
    Scheuplein F; Lamont DJ; Poynter ME; Boyson JE; Serreze D; Lundblad LK; Mashal R; Schaub R
    PLoS One; 2015; 10(10):e0140729. PubMed ID: 26474487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of CD8+ invariant NKT cells in mice.
    Lee H; Hong C; Shin J; Oh S; Jung S; Park YK; Hong S; Lee GR; Park SH
    Exp Mol Med; 2009 Dec; 41(12):866-72. PubMed ID: 19745607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invariant NKT cell development requires a full complement of functional CD3 zeta immunoreceptor tyrosine-based activation motifs.
    Becker AM; Blevins JS; Tomson FL; Eitson JL; Medeiros JJ; Yarovinsky F; Norgard MV; van Oers NS
    J Immunol; 2010 Jun; 184(12):6822-32. PubMed ID: 20483726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Analysis of iNKT Cell Development and Function.
    Sahler J; Anannya O; Limper C; Imbiakha B; Pierpont T; August A
    Methods Mol Biol; 2021; 2388():1-12. PubMed ID: 34524657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
    Rieder SA; Nagarkatti P; Nagarkatti M
    Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.
    Liu J; Gallo RM; Khan MA; Iyer AK; Kratzke IM; Brutkiewicz RR
    Eur J Immunol; 2019 Feb; 49(2):255-265. PubMed ID: 30467836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
    Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
    J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-13 Pathway Alterations Impair Invariant Natural Killer T-Cell-Mediated Regulation of Effector T Cells in Type 1 Diabetes.
    Usero L; Sánchez A; Pizarro E; Xufré C; Martí M; Jaraquemada D; Roura-Mir C
    Diabetes; 2016 Aug; 65(8):2356-66. PubMed ID: 27207542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
    Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
    PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells.
    Caielli S; Conforti-Andreoni C; Di Pietro C; Usuelli V; Badami E; Malosio ML; Falcone M
    J Immunol; 2010 Dec; 185(12):7317-29. PubMed ID: 21078913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ins and outs of type I iNKT cell development.
    Shissler SC; Webb TJ
    Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
    Guan P; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
    J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.
    Speak AO; Platt N; Salio M; te Vruchte D; Smith DA; Shepherd D; Veerapen N; Besra GS; Yanjanin NM; Simmons L; Imrie J; Wraith JE; Lachmann RH; Hartung R; Runz H; Mengel E; Beck M; Hendriksz CJ; Porter FD; Cerundolo V; Platt FM
    Eur J Immunol; 2012 Jul; 42(7):1886-92. PubMed ID: 22585405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation strategies for invariant natural killer T cells.
    Kohlgruber AC; Donado CA; LaMarche NM; Brenner MB; Brennan PJ
    Immunogenetics; 2016 Aug; 68(8):649-63. PubMed ID: 27457886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.